U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Books

Items: 15

1.
The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study
Jong Hyun Pyun, Nak-Hoon Son, Young Hwii Ko, Sang Won Kim, Hoseob Kim, Yoon-Jong Bae
World J Mens Health. 2024 Apr; 42(2): 460–466. Published online 2024 Jan 2. doi: 10.5534/wjmh.230137
PMCID:
PMC10949023
AbstractArticlePDF–1.5M
2.
Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women
Akshunna Keerti, Bhushan Madke, Akshaya Keerti, Mark Joseph C Lopez, Francesca S Lirio
Cureus. 2023 Sep; 15(9): e44949. Published online 2023 Sep 9. doi: 10.7759/cureus.44949
PMCID:
PMC10561660
AbstractArticlePDF–469K
3.
Association of 5α-Reductase Inhibitor Prescription With Bladder Cancer Progression in Males in South Korea
Min Ho An, Min Seo Kim, Chungsoo Kim, Tae Il Noh, Kwan Joong Joo, Dong Hun Lee, Kyu-Ho Yi, Jeong Woo Kwak, Tae-Ho Hwang, Rae Woong Park, Seok Ho Kang
JAMA Netw Open. 2023 May; 6(5): e2313667. Published online 2023 May 16. doi: 10.1001/jamanetworkopen.2023.13667
PMCID:
PMC10189569
AbstractArticle
4.
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
B.M. Piraccini, U. Blume‐Peytavi, F. Scarci, J.M. Jansat, M. Falqués, R. Otero, M.L. Tamarit, J. Galván, V. Tebbs, E. Massana, the Topical Finasteride Study Group
J Eur Acad Dermatol Venereol. 2022 Feb; 36(2): 286–294. Published online 2021 Oct 25. doi: 10.1111/jdv.17738
Correction in:
J Eur Acad Dermatol Venereol. 2023 Feb; 37(2): 452.
PMCID:
PMC9297965
AbstractArticlePDF–459K
5.
5-alpha reductase inhibitors and prostate cancer mortality among men with regular access to screening and health care
Jane B. Vaselkiv, Carl Ceraolo, Kathryn M. Wilson, Claire H. Pernar, Emily M. Rencsok, Konrad H. Stopsack, Sydney T. Grob, Anna Plym, Edward L. Giovannucci, Aria F. Olumi, Adam S. Kibel, Mark A. Preston, Lorelei A. Mucci
Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2023 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Jul 1; 31(7): 1460–1465. doi: 10.1158/1055-9965.EPI-21-1234
PMCID:
PMC9250593
AbstractArticlePDF–133K
6.
Evaluation of long‐term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system
Jung‐Won Shin, Euy‐Hyun Chung, Moon‐Bum Kim, Tae‐Ook Kim, Woo‐Il Kim, Chang‐Hun Huh
J Dermatol. 2019 Feb; 46(2): 139–143. Published online 2018 Dec 7. doi: 10.1111/1346-8138.14719
PMCID:
PMC6587453
AbstractArticlePDF–327K
7.
Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
Yu Seob Shin, Keshab Kumar Karna, Bo Ram Choi, Jong Kwan Park
World J Mens Health. 2019 May; 37(2): 157–165. Published online 2018 Aug 10. doi: 10.5534/wjmh.180029
PMCID:
PMC6479090
AbstractArticlePDF–495K
8.
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial
Javier Hernandez, Jonathan Gelfond, Martin Goros, Michael A. Liss, Yuanyuan Liang, Donna Ankerst, Ian M. Thompson, Jr., Robin J. Leach
PLoS One. 2018; 13(10): e0204823. Published online 2018 Oct 9. doi: 10.1371/journal.pone.0204823
PMCID:
PMC6177134
AbstractArticlePDF–1.0M
9.
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
Joseph M. Unger, Cathee Till, Ian M. Thompson, Jr., Catherine M. Tangen, Phyllis J. Goodman, Jason D. Wright, William E. Barlow, Scott D. Ramsey, Lori M. Minasian, Dawn L. Hershman
J Natl Cancer Inst. 2016 Dec; 108(12): djw168. Published online 2016 Aug 26. doi: 10.1093/jnci/djw168
PMCID:
PMC5241895
AbstractArticlePDF–742K
10.
Contraindicated use of 5‐alpha‐reductase inhibitors in women
Martina Teichert, Eugene van Puijenbroek, Bruno H. Stricker
Br J Clin Pharmacol. 2017 Feb; 83(2): 429–431. Published online 2016 Sep 30. doi: 10.1111/bcp.13118
PMCID:
PMC5237684
ArticlePDF–230K
11.
Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review
Jason M. Hirshburg, Petra A. Kelsey, Chelsea A. Therrien, A. Carlo Gavino, Jason S. Reichenberg
J Clin Aesthet Dermatol. 2016 Jul; 9(7): 56–62. Published online 2016 Jul 1.
PMCID:
PMC5023004
AbstractArticlePDF–125K
12.
Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
Angela B Smith, Culley C Carson
Ther Clin Risk Manag. 2009; 5: 535–545. Published online 2009 Jul 12. doi: 10.2147/tcrm.s6195
PMCID:
PMC2710385
AbstractArticlePDF–196K
13.
The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination
Per Olsson Gisleskog, David Hermann, Margareta Hammarlund-Udenaes, Mats O Karlsson
Br J Clin Pharmacol. 1999 Jan; 47(1): 53–58. doi: 10.1046/j.1365-2125.1999.00843.x
PMCID:
PMC2014202
AbstractArticlePDF–172K
14.
Comparison of Clinical Trials With Finasteride and Dutasteride
J. Curtis Nickel
Rev Urol. 2004; 6(Suppl 9): S31–S39.
PMCID:
PMC1472914
AbstractArticlePDF–142K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center